These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 6775032)
21. Interaction of turkey complement with Escherichia coli isolated from turkeys. Ellis MG; Arp LH; Lamont SJ Am J Vet Res; 1989 Aug; 50(8):1285-9. PubMed ID: 2675694 [TBL] [Abstract][Full Text] [Related]
22. Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera. Clas F; Loos M Immunology; 1980 Aug; 40(4):547-56. PubMed ID: 6776034 [TBL] [Abstract][Full Text] [Related]
23. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens. Traub WH; Fukushima PI Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. Sahu A; Kay BK; Lambris JD J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942 [TBL] [Abstract][Full Text] [Related]
25. Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. McQuillen DP; Gulati S; Ram S; Turner AK; Jani DB; Heeren TC; Rice PA J Infect Dis; 1999 Jan; 179(1):124-35. PubMed ID: 9841831 [TBL] [Abstract][Full Text] [Related]
26. [Isolation of low-molecular-mass antibacterial mixtures from human seminal plasma]. Zhao H; Shen JH; Li WH; Zhang Y; Li H Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):842-6. PubMed ID: 19024329 [TBL] [Abstract][Full Text] [Related]
27. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Des Prez RM; Bryan CS; Hawiger J; Colley DG Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523 [TBL] [Abstract][Full Text] [Related]
28. The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis. Kitamura H; Nagaki K; Inoshita K; Iida K; Inai S Clin Exp Immunol; 1977 Jan; 27(1):34-7. PubMed ID: 849648 [TBL] [Abstract][Full Text] [Related]
29. Hereditary C3 hypocomplementemia in the rabbit. Komatsu M; Yamamoto K; Nakano Y; Nakazawa M; Ozawa A; Mikami H; Tomita M; Migita S Immunology; 1988 Jul; 64(3):363-8. PubMed ID: 3410489 [TBL] [Abstract][Full Text] [Related]
30. A reason for the cytolytic inefficiency of murine serum. Sassi F; Hugo F; Muhly M; Khaled A; Bhakdi S Immunology; 1987 Sep; 62(1):145-7. PubMed ID: 3308691 [TBL] [Abstract][Full Text] [Related]
31. The role of complement and antibodies in the impaired bactericidal activity of neonatal sera against gram-negative bacteria. Jankowski S Acta Microbiol Pol; 1995; 44(1):5-14. PubMed ID: 7660858 [TBL] [Abstract][Full Text] [Related]
32. Identification of alternative pathway serum complement activity in the blood of the American alligator (Alligator mississippiensis). Merchant ME; Roche CM; Thibodeaux D; Elsey RM Comp Biochem Physiol B Biochem Mol Biol; 2005 Jul; 141(3):281-8. PubMed ID: 15921941 [TBL] [Abstract][Full Text] [Related]
33. The role of C9 in complement-mediated killing of Neisseria. Harriman GR; Esser AF; Podack ER; Wunderlich AC; Braude AI; Lint TF; Curd JG J Immunol; 1981 Dec; 127(6):2386-90. PubMed ID: 6795273 [TBL] [Abstract][Full Text] [Related]
34. Membrane cofactor protein (CD46) in seminal plasma is a prostasome-bound form with complement regulatory activity and measles virus neutralizing activity. Kitamura M; Namiki M; Matsumiya K; Tanaka K; Matsumoto M; Hara T; Kiyohara H; Okabe M; Okuyama A; Seya T Immunology; 1995 Apr; 84(4):626-32. PubMed ID: 7790037 [TBL] [Abstract][Full Text] [Related]
35. Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. Joiner KA; Warren KA; Hammer C; Frank MM J Immunol; 1985 Mar; 134(3):1920-5. PubMed ID: 3918112 [TBL] [Abstract][Full Text] [Related]
36. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients. Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709 [TBL] [Abstract][Full Text] [Related]
37. Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4. Tedesco F; Rottini G; Patriarca P J Immunol; 1981 Nov; 127(5):1910-5. PubMed ID: 7028865 [TBL] [Abstract][Full Text] [Related]
38. Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with sepharose derivatives on the anticoagulant. Nakanishi K; Zbar B; Borsos T Cancer Res; 1985 Sep; 45(9):4122-7. PubMed ID: 3928150 [TBL] [Abstract][Full Text] [Related]
39. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. Low PJ; Ai R; Ogata RT J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274 [TBL] [Abstract][Full Text] [Related]
40. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen. Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ J Androl; 2005; 26(1):146-52. PubMed ID: 15611579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]